Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation

Transplantation

Volumn 62, Issue 5, 1996, Pages 672-678

  Bouma, Gerda J ^a   Van Caubergh, Patricia ^a   Van Bree, Simone P M J ^a   Castelli Visser, Ria M C ^a   Witvliet, Marian D ^a   Van Der Meer Prins, Ellen M W ^a   Van Rood, Jon J ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD8 ANTIGEN; HLA ANTIGEN; OKT 8;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; ORGAN DONOR; PREGNANCY; PRIORITY JOURNAL;

EID: 0029809492     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609150-00023     Document Type: Article

References (40)

1. Albrechtsen D, Leivestad T, Fauchald P, Flatmark A, Sodal G, Thorsby E. Results of the National Kidney Transplantation Program in Norway. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 207.
2. Haberal M, Gulay H, Tokyay R, Oner Z, Enunlu T, Bilgin N. Living unrelated donor kidney transplantation between spouses. World J Surg 1992; 16: 1183.
3. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
4. Pirsch JD, Sollinger HW, Kalayoglu M, et al. Living-unrelated renal transplantation: results in 40 patients. Am J Kidney Dis 1988; 12: 499.
5. Squifflet JP, Pirson Y, Poncelet A, Gianello P, Alexandre GPJ. Unrelated living donor kidney transplantation. Transpl Int 1990; 3: 32.
6. Jones J, Payne WD, Matas AJ. The living donor-risks, benefits and related concerns. Transplant Rev 1993; 7: 115.
7. Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994; 57: 1450.
8. Stastny P. Tissue typing antisera from immunization by pregnancy. Tissue Antigens 1972; 2: 123.
9. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6: 294.
10. Salvatierra O Jr, Iwaki Y, Vincenti F, et al. Update of the University of California at San Francisco experience with donor-specific blood transfusions. Transplant Proc 1982; 14: 363.
11. Scornik JC, Salomon DR, Lim PB, Howard RJ, Pfaff WW. Post-transplant antidonor antibodies and graft rejection. Transplantation 1989; 47: 287.
12. Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation. Transplantation 1992; 54: 389.
13. Suciu-Foca N, Reed E, D'Agati VD, et al. Soluble HLA antigens, anti-HLA antibodies, and anti-idiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991; 51: 593.
14. Williams GM. Clinical course following transplantation. In: Morris PJ, ed. Kidney transplantation: principles and practice, 2nd ed. New York: Grune & Stratton, 1984: 335.
15. Mason DW, Morris PJ. Effector mechanisms in allograft rejection. Annu Rev Immunol 1986; 4: 119.
16. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
17. Bouma GJ, Van der Meer-Prins PMW, Van der Woude FJ, Van Rood JJ, Claas FHJ. Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival. Transplantation 1995; 59: 969.
18. MacDonald HR, Cerottini J-C, Ryser J-E, et al. Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev 1980; 51: 93.
19. Hess AD, Tutschka PJ. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J Immunol 1980; 124: 2601.
20. Hess AD, Tutschka PF, Santo GW. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol 1982; 128: 355.
21. Heeg K, Deusch K, Solbach W, Bunjcs D, Wagner H. Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors. Transplantation 1984; 38: 532.
22. Kabelitz D, Zanker B, Zanker C, Heeg K, Wagner H. Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors. Immunology 1987; 61: 57.
23. Orosz CG, Adams PW, Ferguson RM. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction. Transplantation 1988; 46: 73S.
24. MacDonald HR, Glasebrook AL, Bron C, Kelso A, Cerottini J-C. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implication for the affinity of CTL antigen receptors. Immunol Rev 1982; 68: 89.
25. Malissen B, Rebai N, Liabeuf A, Mawas C. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur J Immunol 1982; 12: 739.
26. Wood PJ, Streilein JW. Mechanisms of transplantation tolerance: the nature of T cell repertoire modification in neonatal tolerance. Transplant Proc 1987; 19: 483.
27. Kane KP, Sherman LA, Mescher MF. Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes. J Immunol 1989; 142: 4153.
28. O'Rourke AM, Mescher MF. The roles of CDS in cytotoxic T lymphocyte function. Immunol Today 1993; 14: 183.
29. Ouwehand AJ, Baan CC, Roelen DL, et al. The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation 1993; 56: 1223.
30. Roelen DL, Van Beelen E, Van Bree FPMJ, Van Rood JJ, Völker-Dieben HJ, Claas FHJ. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation 1995; 59: 1039.
31. Roelen D, Datema G, Van Bree S, Zhang L, Van Rood J, Claas F. Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen. Transplantation 1992; 53: 899.
32. Schreuder GMT, Hendriks GFJ, D'Amaro J, Persijn GG. An eight-year study of HLA-typing proficiency in Eurotransplant. Tissue Antigens 1986; 27: 131.
33. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 1978; 69: 103.
34. Bouma GJ, Van der Meer-Prins PMW, Van Bree FPMJ, Van Rood JJ, Claas FHJ. Determination of cytotoxic T-lymphocyte precursor frequencies using Europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol 1992; 35: 82.
35. Sharrock CEM, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990; 11: 281.
36. Strybosch LWG, Buurman WA, Does RJM, Zinken PH, Groenewegen G. Limiting dilution assays: experimental design and statistical analysis. J Immunol Methods 1987; 97: 133.
37. Manyonda IT, Pereira RS, Pearce JM, Sharrock CEM. Limiting dilution analysis of the allo-MHC anti-paternal cytotoxic T cell response. I. Normal primigravid and multiparous pregnancies. Clin Exp Immunol 1993; 93: 126.
38. Roelen DL, Van Bree FPMJ, Witvliet MD, et al. IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not. Transplantation 1994; 57: 1388.
39. Claas FHJ, De Waal LP, Beelen J, et al. Transplantation of highly sensitized patients on the basis of acceptable HLA-A and -B mismatches. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1990; 185.
40. Roelen DL. Activated HLA class I reactive T lymphocytes (CTLs) associated with a positive historical crossmatch predicts early graft failure. In: Differential role of naive versus primed cytotoxic T cells in clinical transplantation. Doctoral thesis, University of Leiden, Leiden, The Netherlands, 1994; 99.